Armistice Capital reports 9.99% stake in GEOVAX

GEOVAX LABS, INC. ownership disclosure: Armistice Capital, LLC and Steven Boyd report beneficial ownership of 291,155 shares of Common Stock, representing 9.99% of the class as set forth in this amendment.

Rhea-AI Filing Summary

GEOVAX LABS, INC. ownership disclosure: Armistice Capital, LLC and Steven Boyd report beneficial ownership of 291,155 shares of Common Stock, representing 9.99% of the class as set forth in this amendment. The filing states Armistice Capital exercises shared voting and dispositive power over those shares.

Insights

Institutional Ownership Analyst

Armistice reports a near-10% position managed via its Master Fund.

Armistice Capital, acting as investment manager to Armistice Capital Master Fund Ltd., is reported to have shared voting and dispositive power over 291,155 shares, equal to 9.99%. The filing attributes beneficial ownership to the manager and to Steven Boyd as managing member.

Future disclosures may show transactions by the Master Fund; the filing states the Master Fund retains the right to receive proceeds from sales.

Corporate Governance Specialist

Structure clarifies manager/entity relationship and disclaimers.

The statement explains that the Master Fund is the direct holder while Armistice Capital, under an Investment Management Agreement, exercises voting and investment power. Mr. Boyd is reported as a managing member and may be deemed to beneficially own the securities by virtue of that role.

The Master Fund "specifically disclaims beneficial ownership" of the securities to the extent it lacks voting or dispositive power under the agreement.

Key Figures

Beneficial ownership: 291,155 shares Percent of class: 9.99% CUSIP: 373678705 +2 more

5 metrics

Beneficial ownership 291,155 shares Amount beneficially owned as reported

Percent of class 9.99% Percent of class as reported

CUSIP 373678705 CUSIP for Common Stock $0.001 par value

Filing amendment date 05/15/2026 Signature Date on the amendment

Reporting period reference 03/31/2026 Date appearing near the cover data

Key Terms

beneficially owned, Investment Management Agreement, Schedule 13G/A

3 terms

beneficially owned financial

"Amount beneficially owned: 291,155"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Investment Management Agreement legal

"pursuant to an Investment Management Agreement, Armistice Capital exercises voting"

An investment management agreement is a written contract that hires a professional to make buying, selling and strategy decisions for an investment account or fund, and sets out their duties, fees, risk limits, performance measures and reporting requirements. It matters to investors because the agreement determines who controls the money, how much the service costs, what risks are allowed, and how success or failure is measured—think of it as the service contract that defines expectations and remedies for a hired portfolio manager.

Schedule 13G/A regulatory

"FORM TYPE: SCHEDULE 13G/A amendment language"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Armistice Capital report in GEOVAX LABS (GOVX)?

Armistice Capital reports beneficial ownership of 291,155 shares, or 9.99% of the class. The filing attributes shared voting and dispositive power to Armistice Capital as investment manager of the Master Fund and names Steven Boyd as managing member.

Who holds the reported GEOVAX shares on behalf of Armistice Capital?

The Armistice Capital Master Fund Ltd. is the direct holder of the reported shares. Armistice Capital is the investment manager and exercises voting and investment power pursuant to an Investment Management Agreement, per the filing language.

Does the Master Fund claim beneficial ownership of the shares?

No— the Master Fund specifically disclaims beneficial ownership by virtue of its lack of voting or dispositive power under the Investment Management Agreement. The filing nonetheless lists the Master Fund as the direct holder with Armistice exercising control.

What voting and disposition powers are reported for the 291,155 shares?

The filing reports 0 shares as sole voting/dispositive power and 291,155 shares as shared voting and shared dispositive power. This indicates control is reported as shared rather than sole for both voting and disposition functions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 11:19 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

GEOVAX LABS, INC.

(Name of Issuer)

Common Stock $0.001 par value

(Title of Class of Securities)

373678705

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 373678705

1

Names of Reporting Persons

Armistice Capital, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 291,155.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 291,155.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

291,155.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

IA, OO

SCHEDULE 13G

CUSIP Number(s): 373678705

1

Names of Reporting Persons

Steven Boyd

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 291,155.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 291,155.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

291,155.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: GEOVAX LABS, INC.
(b)	Address of issuer's principal executive offices: 1900 Lake Park Drive, Suite 380, Smyrna, Georgia 30080
Item 2.
(a)	Name of person filing: Armistice Capital, LLC Steven Boyd Collectively, the "Reporting Persons"
(b)	Address or principal business office or, if none, residence: Armistice Capital, LLC 510 Madison Avenue, 7th Floor New York, New York 10022 United States of America Steven Boyd c/o Armistice Capital, LLC 510 Madison Avenue, 7th Floor New York, New York 10022 United States of America
(c)	Citizenship: Armistice Capital, LLC - Delaware; Steven Boyd - United States of America
(d)	Title of class of securities: Common Stock $0.001 par value
(e)	CUSIP No.: 373678705
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 291,155
(b)	Percent of class: 9.99%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 291,155
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 291,155 Armistice Capital, LLC ("Armistice Capital") is the investment manager of Armistice Capital Master Fund Ltd. (the "Master Fund"), the direct holder of the Shares, and pursuant to an Investment Management Agreement, Armistice Capital exercises voting and investment power over the securities of the Issuer held by the Master Fund and thus may be deemed to beneficially own the securities of the Issuer held by the Master Fund. Mr. Boyd, as the managing member of Armistice Capital, may be deemed to beneficially own the securities of the Issuer held by the Master Fund. The Master Fund specifically disclaims beneficial ownership of the securities of the Issuer directly held by it by virtue of its inability to vote or dispose of such securities as a result of its Investment Management Agreement with Armistice Capital.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The Master Fund, a Cayman Islands exempted company that is an investment advisory client of Armistice Capital, has the right to receive dividends from, or the proceeds from the sale of, the reported securities.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Armistice Capital, LLC

Signature:	/s/ Steven Boyd
Name/Title:	Steven Boyd - Managing Member
Date:	05/15/2026

Steven Boyd

Signature:	/s/ Steven Boyd
Name/Title:	Steven Boyd
Date:	05/15/2026

Exhibit Information

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Dated: February 17, 2026 Armistice Capital, LLC By: /s/ Steven Boyd Steven Boyd - Managing Member Steven Boyd By: /s/ Steven Boyd